抗アレルギー効果のあるKW乳酸菌の発見と活用
|
|
|
- うたろう うみのなか
- 7 years ago
- Views:
Transcription
1 KW Strachan BCG Lactobacillus Lactococcus Streptococcus Lactobacillus casei brevis johnsonii
2 Th2 Th2 IL 4 B IgE IgE IgE IL-12 IL-12 Th1 Th1 Th2 Th2 Th1 Th2 KW 101 Th1/Th2 BALB/c
3 OVA 2 Th2 OVA OVA Th2 OVA Th2 Th1 Th1 IL-12 Th2 IL-4 IL-12 IL-12 IL-12 Lactobacillus paracasei KW3110 IL-4 IL-4 IL-4 L. paracasei KW3110 L. paracasei L. paracasei
4 LPS LTA IL-12 NF-κB KW3110 LTA NF-κB LTA LTA data not shown LTA CpG DNA KW3110 KW3110 BALB/c 2 1 AIN mg KW OVA IgE OVA IL-12 IL-4 KW3110 Th1/Th2 IgE OVA IgE OVA IgE OVA KW3110
5 IgE 98 IgE OVA IL-12 KW3110 IL-4 KW3110 KW3110 CD40 B7-1 data not shown KW3110 Th1 Th2 IgE 1mg/mouse/day KW3110 KW L. paracasei KW Th1/Th2 5 L. delbrueckii B 200ml cfu IgE IgE Th1/Th2 ECP
6 Th1/Th2 B 1 4 Th1/Th2 p= Th1 Th2 data not shown KW3110 Th1/Th2 B 3 KW ECP B 1 4 ECP p= KW3110 ECP B 3 KW3110 8
7 IgE KW3110 B data not shown KW3110 data not shown KW3110 KW3110 KW3110 IgE NC/Nga 2 1 AIN mg KW IgE KW3110 KW3110 KW3110 data not shown IgE KW3110
8 KW3110 KW3110 KW KW
9 Th1/Th2 KW 8 8 Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275:77-9. Aaby P, Shaheen SO, Heyes CB, Goudiaby A, Hall, Shiell AJ AW, Jensen H, Marchant A. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy. 2000; 30: The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Daisuke Fujiwara, Sayo Inoue, Hideyuki Wakabayashi and Toshio Fujii A double-blind trial of Lactobacillus paracasei KW3110 strain administration for immunomodulation in patients with pollen allergy. Daisuke Fujiwara, Hideyuki Wakabayashi, Hiroyuki Watanabe, Satoshi Nishida and Hisakazu Iino
10 IL-12 IL-4 IL-12 IL-4 IL-12 (% of KW3110) IL-4 (% of control) KW3110 L. paracasei 100 KW3110 L. paracasei 26.4 KW4510 L. lindneri 95.8 KW3119 L. casei 27.5 KW4110 L plantarum 93.9 KW3917 L. paracasei 29.8 KW3210 S. salivarius 77.7 KW3911 L. paracasei 29.8 KW3925 L. paracasei 77.1 KW3926 L. paracasei 30.2 KW3811 L. brevis 76.1 KW3914 L. paracasei 35.7 KW3926 L. paracasei 70.1 KW3913 L. paracasei 36.3 KW3213 S. salivarius 65.3 KW3111 L. casei 36.3 KW4310 L. mesenteroides 57.4 KW4010 L. gasseri 36.7 KW3119 L. casei 56.0 KW4110 L plantarum 36.7 KW3927 L. paracasei 53.7 KW3317 L. delbrueckii 42.6 KW4010 L. gasseri 53.2 KW3929 L. paracasei 43.0 KW4610 L. rhamnosus 52.6 KW4310 L. mesenteroides 43.4 KW3118 L. casei 48.8 KW3120 L. casei 43.9 KW3824 L. brevis 46.7 KW4610 L. rhamnosus 45 KW3411 L. acidophilus 44.2 KW3925 L. paracasei 45.2 KW3112 L. casei 43.6 KW3927 L. paracasei 45.3 KW3920 L. paracasei 43.2 KW3118 L. casei 45.7 KW3111 L. casei 42.1 KW3114 L. casei 46.2 KW3813 L. brevis 41.5 KW3923 L. paracasei 47.7 KW3914 L. paracasei 39.5 KW3934 L. paracasei 48.7 KW3928 L. paracasei 39.2 KW3112 L. casei 48.8 KW3120 L. casei 38.8 KW3931 L. paracasei 49.0 KW3410 L. acidophilus 38.7 KW3410 L. acidophilus 49.2 KW3911 L. paracasei 38.5 KW3214 S. salivarius 49.5 KW3917 L. paracasei 38.4 KW3210 S. salivarius 49.9 KW3113 L. casei 38.3 KW3933 L. paracasei 50.1 KW3941 L. paracasei 38.3 KW3941 L. paracasei 50.3 KW3816 L. brevis 37.7 KW3936 L. paracasei 54 KW3828 L. brevis 37.2 KW3113 L. casei 54.8 KW3214 S. salivarius 37.2 KW3213 S. salivarius 54.8 KW3923 L. paracasei 37.2 KW3915 L. paracasei 54.9 KW3211 S. salivarius 37.1 KW4611 L. rhamnosus 55.4 KW3924 L. paracasei 35.1 KW3211 S. salivarius 56.8
11 KW3826 L. brevis 34.3 KW3932 L. paracasei 57.0 KW3822 L. brevis 33.8 KW3924 L. paracasei 57.0 KW3821 L. brevis 33.0 KW3939 L. paracasei 59.1 KW3820 L. brevis 30.8 KW3930 L. paracasei 59.7 KW3929 L. paracasei 30.7 KW3928 L. paracasei 59.8 KW3825 L. brevis 29.5 KW3912 L. paracasei 61.1 KW3823 L. brevis 28.8 KW3922 L. paracasei 61.6 KW3913 L. paracasei 28.2 KW3413 L. acidophilus 63.6 KW4211 L. johnsonii 26.7 KW3935 L. paracasei 63.7 KW3114 L. casei 26.2 KW3920 L. paracasei 63.7 KW3413 L. acidophilus 25.6 KW3411 L. acidophilus 66.7 KW3317 L. delbrueckii 21.9 KW3311 L. delbrueckii 66.9 KW4511 L. lindneri 21.4 KW3212 S. salivarius 67.1 KW3930 L. paracasei 19.5 KW3919 L. paracasei 67.4 KW3311 L. delbrueckii 19.4 KW3116 L. casei 68.3 KW3931 L. paracasei 19.3 KW3921 L. paracasei 68.7 KW3919 L. paracasei 19.1 KW4510 L. lindneri 69.0 KW3212 S. salivarius 19 KW3938 L. paracasei 69.8 KW3814 L. brevis 18.7 KW3712 L. helbeticus 70.7 KW3817 L. brevis 18.1 KW3115 L. casei 72.4 KW3712 L. helbeticus 18 KW3117 L. casei 73.4 KW3932 L. paracasei 17.9 KW3810 L. brevis 74.6 KW3412 L. acidophilus 17.1 KW3414 L. acidophilus 74.6 KW3933 L. paracasei 17.1 KW3513 B. breve 74.7 KW3810 L. brevis 16.4 KW3711 L. helbeticus 75.0 KW3912 L. paracasei 14.4 KW3822 L. brevis 76.7 KW3812 L. brevis 13.9 KW3412 L. acidophilus 78.0 KW3414 L. acidophilus 11.7 KW3811 L. brevis 78.5 KW3316 L. delbrueckii 10.7 KW3515 B. longum 79.3 KW3613 L. lactis 10.6 KW3511 B. longum 80.0 KW3915 L. paracasei 10.5 KW3825 L. brevis 80.9 KW3116 L. casei 10.3 KW3824 L. brevis 81.3 KW3922 L. paracasei 10.0 KW4211 L. johnsonii 82.8 KW3910 L. paracasei 9.0 KW3910 L. paracasei 83.0 KW3934 L. paracasei 8.1 KW3826 L. brevis 87.2 KW3921 L. paracasei 7.9 KW3823 L. brevis 87.9 KW3513 B. breve 7.5 KW3916 L. paracasei 89.7 KW3315 L. delbrueckii 7.4 KW3315 L. delbrueckii 90.4
12 KW3827 L. brevis 7.4 KW3918 L. paracasei 93.2 KW3815 L. brevis 5.9 KW4704 L. kefiri 94.3 KW3935 L. paracasei 5.5 KW4702 L. kefiri 96.5 KW3611 L. lactis 5.3 KW3828 L. brevis 98.4 KW3936 L. paracasei 5.1 control KW3710 L. helbeticus 5.1 KW3821 L. brevis KW3818 L. brevis 4.7 KW3820 L. brevis KW3115 L. casei 4.5 KW4703 L. kefiri KW3117 L. casei 4.5 KW3610 L. lactis KW3916 L. paracasei 4.3 KW3510 B. lactis KW3310 L. delbrueckii 3.6 KW3612 L. lactis KW4700 L. kefiri 3.6 KW4700 L. kefiri KW4701 L. kefiri 2.6 KW3813 L. brevis KW3939 L. paracasei 2.3 KW3310 L. delbrueckii KW4704 L. kefiri 2.3 KW3827 L. brevis KW4702 L. kefiri 2.1 KW3817 L. brevis KW3918 L. paracasei 2.0 KW3818 L. brevis KW4210 L. johnsonii 1.8 KW3816 L. brevis KW3819 L. brevis 1.8 KW3611 L. lactis KW3711 L. helbeticus 1.5 KW4511 L. lindneri KW4611 L. rhamnosus 1.3 KW4701 L. kefiri KW3938 L. paracasei 1.2 KW3819 L. brevis KW3514 B. infantis 1.2 KW3514 B. infantis KW3610 L. lactis 1.0 KW3815 L. brevis KW3510 B. lactis 0.5 KW3710 L. helbeticus control 0.2 KW3316 L. delbrueckii KW3511 B. longum 0.0 KW3814 L. brevis KW3515 B. longum 0.0 KW3812 L. brevis KW3612 L. lactis 0.0 KW4210 L. johnsonii KW4703 L. kefiri 0.0 KW3613 L. lactis 187.8
:,, : - 7 -
31 ~ ~ - 6 - :,, : - 7 - (),,,,,,; ~ ~ *1 *2 6,,,~,,~ - 8-32 ,, ( );( ),,,,,, ~ ~ ~,,,, (),,,,, - 9 - 33 ~*~ ~~ ~, ~ ~ ~ ~ ~, ~~,,,, - 10 - BCG () g ) BCG BCG,, 34 ,,,, (),,,,,,,,,,,,,, () ( 3 90 [7 6
Do probiotic bacteria improve human oral microbiota? NOBUKO MAEDA, TOMOKO OHSHIMA, KENICHI HOJO and NAOKI TAKETOMO The term eprobiotics f is defined a
Do probiotic bacteria improve human oral microbiota? NOBUKO MAEDA, TOMOKO OHSHIMA, KENICHI HOJO and NAOKI TAKETOMO The term eprobiotics f is defined as eliving microorganisms that exhibit beneficial effects
野岩鉄道の旅
29th 5:13 5:34 5:56 6:00 6:12 6:20 6:21 6:25 6:29 6:31 6:34 6:38 6:40 6:45 6:52 6:56 7:01 7:07 7:11 7:32 7:34 7:50 7:58 8:03 8:17 8:36 8:44 5:50 5:54 6:15 6:38 6:39 6:51 6:59 6:59 7:03 7:08 7:08 7:11 7:15
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
スギ花粉症モデルマウスにおけるユーグレナの効果についての検討
[ 研究ノート ] Effect of euglena on cedar pollen allergies in cry j-sensitized mice Miki Koizumi, Yui Yoshii, Masahiro Yuasa, Hiromi Sawamura, Toshiaki Watanabe, Eriko Yoshida, Kengo Suzuki Department of Dietary
0.02ml IgE RAST MAST CAP 2
( ) 1 0.02ml IgE RAST MAST CAP 2 3 1963 30 4 1986 20 39 IgE 30% 1988 54.7% IgE 47.6% 1990 892 IgE 27% 12% 1995 2379 1995 8 15 1996 1 12 2335 98.5% 2335 24 61 47 44.0 1 1) 2335 613 26.3% 2 5 613 43.4 44.2
untitled
...1... 3 1... 3 2... 4 3... 4 4... 5...... 6 1... 6 2... 7 3... 8 4... 9 5... 10... 12 1... 12 2... 13 3... 14 4... 16...... 19 1... 19 2... 20 3... 22 4... 24...... 25... 26 1... 26 2... 26 3... 26......
第３章 焼却灰溶融システムの現状、焼却灰溶融スラグのリサイクルの動向・問題点
18 5 23 450 100~150 1300 1998 10 25 1 1 27 1819 60 3 300t 28.8t 2 62 118t16 12.3 16h 24 3 4 120t 9.6t24h 3 4 100t24h 15t24h 3 4 600t24h 500t24h 5 2 300t24h 75t24h 6 8 80 24h 9.6 24h 4 300t24h 52 24 11
研究成果報告書(基金分)
(1) 種類 程度 肥満細胞数の測定と組織でのサ RT-PCR FACS () (1) NMU-/- IgE NMU IgE -/-NMU -/-B IgE NMU -/-B6 IgE NMU NMU CTLMC BMMC IgE NMU CTLMC 13 1. Hayakawa J, Mizukawa Y, Kurata M, Shiohara T: A syringotropic variant
Milk Science Vol. 60, No 原著論文 MRS 寒天培地と変法 LBS 寒天培地における乳酸菌の選択的単離能の比較 木下英樹 井本瞬 須田義人 石田光晴 ( 宮城大学食産業学部 ) Comparison of selectivity of MRS agar and
Milk Science Vol. 60, No. 3 2011 原著論文 MRS 寒天培地と変法 LBS 寒天培地における乳酸菌の選択的単離能の比較 木下英樹 井本瞬 須田義人 石田光晴 ( 宮城大学食産業学部 ) Comparison of selectivity of MRS agar and modiˆed LBS agar for isolation of lactobacilli Hideki
微生物遺伝資源利用マニュアル(15)
(15) MAFF Microorganism Genetic Resources Manual No.15 Lactic acid bacteria isolated from silage DNA G+C 1999 1991a 1994 Lactobacillus plantarum Lactobacillus casei McDonald et al. 1991 2001 Ohmomo et
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
19 8 1970 20 10 4 1
19 8 1970 20 10 4 1 IgE 1960 % 1970 20%, 1990 40% 1998 70% 20 IgE 21 90% IgE IgE (%) 70 60 50 40 30 20 10 0 1970 1975 1980 1985 1990 1995 2000 2005 1. 2005 10 2 30 IgE 2. 3 1. B IgE T IgE IgE IgE 2 T IgE
CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin
CHEMOTHERAPY CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin CHEMOTHERAPY Fig. 1 MICs of sultamicillin against respiratory pathogenic Branhamella catarrhalis 62 strains, inoculum size 106CFU/m1 Fig.
酵素化学
1 2 3 DNA RNA 4 5 6 7 8 9 H 2 O 10 http://www.ultranet.com/~jkimball/biologypages/c/carbohydrates.html#starches http://www.wantashi.com/aroma/refre/page12.html 11 mono : di : 2 tri : 3 poly : 12 13 14
17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) (1) (3) 25. (1) (3) 26. (1) 27. (1) (3) 28. (1) 29. (1) 2
1. (1) 2. 2 (1) 4. (1) 5. (1) 6. (1) 7. (1) 8. (1) 9. (1) 10. (1) 11. (1) 12. (1) 13. (1) 14. (1) 15. (1) (3) 16. (1) 1 17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) 24. 1 (1) (3)
untitled
1 80 28 100 11 7-1- 2.49 1.89 1.29 0.69 1 1 10 50-2- 65 2 75 2 85 2 95 2 Aw -3- ( ) ( ) 5 5 0 10 ( ) ( ) ( ) -4- -5- 100 1 4 100 31 HACCP Hazard Analysis Critical Control Points 62 65 30-6- -7- -8- 100
PM2.5 PM. PM2.5 PM. PM2.5 PM. PM2.5 PM.
PM2.5 5-1457 2628,685 PM2.5 PM. PM2.5 PM. PM2.5 PM. PM2.5 PM. PM2.5 PM. PM2.5 PM2.5 PM.,, PM2.5 PM2.5 PM. PM2.5 PM. PM!"#$%&'()*+,-./0! TLR2! TLR4!!"1# 234# -35# 67! 89:! ;()!!"1# ?@"#$%AB! CD!
ISO
ISO ISO ISO(International Standardization Organization) 135 ISO CD(Committee Draft) DIS(Draft for International Standard) FDIS(Final DIS) ISO ISO23500 2004.01.13 ANSI/AAMI RD52 2004.04.13 6 2004.08.09
Masao INOUE A Proposal on the Use of Audio Visual Teaching in the Teaching of Natural Science in Elementary Schools. Lectures are planned to give students many audio-visual data and cultivate their ability
ほんぶん－第６章.indd
m,m ...,,,..... BCG - /.... T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S
VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity
VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity CHEMOTHERAPY MAR. 1989 Mble 1. Allcrgy in parients nduced by penams VOL. 37 NO. 3 Table 2. Allergy in patients induced by
１ 発病のとき
3 2 1996 1996 539 3 1953 1954 1960 1961 1975 1976 1990 1990 1996 1953 1960 2001 5 11 1975 1990 1996 1 1953 1951 26 112 3 126 127 3 130 22 223 518 2 519 2 623 2 821 540 3 9 27 255 1 1026 2 114 1110 1111
Abbreviation: AD; atopic dermatitis, BA; bronchial asthma, DA; drug allergy, FA; food allergy, BAST; radioallergosolvent test, s. c; subcutaneous
Abbreviation: AD; atopic dermatitis, BA; bronchial asthma, DA; drug allergy, FA; food allergy, BAST; radioallergosolvent test, s. c; subcutaneous Fig. I Total serum IgE and IgE RAST score of egg white
ＰＤＦ変換用（報告書）帯広市新エネルギービジョ
12 1 (260 3)(800 3 40 (800 3 1,300 3 ) 40 60 40 22 18 3738 1 10 1 2 11 5 24 12 8 1 2 15 () 3 26 3 13 6 8 12 3 70 4 16 1 6 4 12 9 30 6,000 70 3,500 5 1,000kw 20 45 27 100 12 11 11 20 1 45 17 11 60 6 20
untitled
37 70,500 135,000 27,700 11 37,400 60,400 8,900 5 40,900 64,900 26,600 4 40,100 47,200 29,700 2 30,500 37,100 24,000 36 62,800 132,000 4,800 20 50,800 72,300 10,800 60 2 7 12 17 67,900 74,872 80,133 83,500
NSKnewsNo503cs5_8 2.indd
プロバイオティクスと感染症 Part 2 杏林大学保健学部教授 学部長神谷茂 はじめに プロバイオティクスの感染症の予防および治療に及ぼす効果が多数論文報告されている その対象感染症は腸管感染症のみならず Helicobacter pylori 感染症 尿路感染症 呼吸器感染症と幅広い 本項ではPart 1に記載した Clostridium ( Clostridioides )difficile 感染症以外の感染症へのプロバイオティクスの効果について解説する
_03_ŠéŒØ
22 217 224 2008 217 2600 1965 40 1985 2007 10,200 /cm 2 2005 571 /cm 2 1989 3,000 1985 1995 2,630 1996 218 2 2007 3,396 20 11521-13424 1992 2000 2006 5.85 15.20 19.85 10 IgE 1986-1995 1996-2005 4/214 1.8
untitled
ver. 3.3JT EVENING PRIMROSE EXTRACT 1 - PMS 1 2 1 4 Oenothera laciniata Oenothera striata Oenothera biennis Oenothera erythrosepala - 2 80 60 40 20 0 1. 2 3 PGGPAC 2. 3 4 ESR3.5 10 5 /g 4 3 1 Helicobacter
プログラム
12 Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis 13 14 Porphyromonas gingivalis fima fi ma Porphyromonas
0.01mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.05 mg/ ç 0.05 mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.0005mg/ ç 0.0005mg/ ç 0.02 mg/ ç 0.02 mg/ ç 0.002 mg/ ç 0.002 mg/ ç 0.004 mg/ ç 0.004 mg/ ç 0.02 mg/ ç 0.02 mg/
Food allergy caused by percutaneous sensitization Food allergy caused by percutaneous sensitization Food allergy caused by percutaneous sensitization Food allergy caused by percutaneous sensitization
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.
2007 18 12 2 3 30 1998 16.2 10 10 1 2008 1 44.5 41.2 39.6 6.0 2.2 1819 Bostock hay fever 4 1964 5 2008 15,673 1 1998 2008 17 300 6 10 23.4 26.5 15.4 2
30 2008 1,172 30 2008 39.6 3 1.5 2008 5 Pollen allergy due to Japanese cedar pollen and preventive measures by Tochigi Prefectural Government Abstract TAKAISHI Masaki, AOYAGI Tatsuya, MASUDA Takashi and
Complex sleep apnea syndrome and sleep disordered breathing in patients with cardiovascular disease V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) Sleep J Clin
368 せることである スターターとして使用する乳酸菌の種類や発酵温度 さらには原料中の溶存酸素濃度など製造条件により 味 香り 食感 物性が異なる 日本では発酵乳とヨーグルトを区別しないで呼称しているが FAO( 国連食糧農業機関 ) とWHO( 世界保健機関 ) により設立された国際政府間機関
身近で活躍する有用微生物 Ⅱ 食品と有用微生物 - 西洋の食文化と微生物 2 ヨーグルトと微生物 モダンメディア 62 巻 11 号 2016[ 身近で活躍する有用微生物 ]367 お小 だむね田宗 Munehiro ODA ひろ宏 はじめに Ⅱ. 発酵乳 ヨーグルトは嗜好性の高い食品である それを毎日摂取すると多様な保健効果を体感できる ヨーグルトの製造では 乳を原料とし それに主役である乳酸菌を働かせることが基本となる
Kishu saba-narezushi narezushi Spinacia oleracea
Kishu saba-narezushi narezushi Spinacia oleracea Department of Applied Biology and Chemistry, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1 1 1 Sakuragaoka, Setagaya-ku, Tokyo 156 8502
Table 1 Patients with various renal function * Ccr, Creatinine clearance ml/min per 1. 48 m2 ** C.V.D., Cerebral vascular disease ; C.R F., Chronic renal failure ; H.D., Hemoclialysis ; D., Dialyzer ;
日本消化器外科学会雑誌第29巻第9号
Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe
喘息について\(公健協会宛02-5作成\)
Q & A Q & A 1.? 20 2. 1) 2) 3) 4) 5) 6) 7) 1) 2) 3) 4) 5) 6) 7) 8) 9) 3. NHK ( ) 4 10 1 200mg ( ) ( 1 ) 4. ( ) ( ) 5. ( ) ( ) 6. β 2 ( ) 7. ( ) 1 8. 1. 2. 3. 4. 5. 6. 7. 8. 9. 2 5 7 1. 1 10 1) 2) 3) 30
(c) () () 1 た の 回 菌 O17が産生する毒素から腸管を護る作用があることも確かめられています 腸内環境改善作用排便回数の少ない女性 39 人に 最初の2 週間はビフィズス菌が含まれない普通の発酵乳を摂取してもらい 続く2 週間の非摂取期の後に BB36 が含まれる発酵乳を2 週間摂取
学術情報 ~ 会員企業のプロバイオティクス研究のいま ~ 森永乳業株式会社研究 情報センター 研究開発体制食品総合研究所 栄養科学研究所 食品基盤研究所 装置開発研究所 分析センター 応用技術センター はじめに 1. BB36 の主な保健作用 森永乳業株式会社 ( 以下 森永乳業 ) は 育児用 森永乳業では 1969 年に BB36 を乳児の腸管内 粉ミルクを研究する中で 母乳栄養児の腸管内にビフィズス菌が多く棲息していることに着目し
Rinku General Medical Center
Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines
Vol.13, No. 1 Japanese Journal of Lactic Acid Bacteria
Japanese Journal of Lactic Acid Bacteria Copyright c 2002, Japan Society for Lactic Acid Bacteria To whom correspondence should be addressed. Phone :+81-3-5477-2549 Fax : +81-3-5477-2459 E-mail : sokada@nodai.ac.jp
1BD BBLCRYSTAL RGP Aerococcus viridans Arcanobacterium pyogenes Bacillus cereus Bacillus licheniformis Bacillus megaterium Bacillus pumilus Bacillus s
111-245150-N-03 21400AMY00151000 20099 1 BD BBLCRYSTAL RGP BD BBLCRYSTAL RGP 4-A 2-A 1-A 4-B 2-B 1-B 4-C 2-C 1-C 4-D 2-D 1-D 4-E 2-E 1-E 4-F 2-F 1-F 4-G 2-G 1-G 4-H 2-H 1-H 4-I 2-I 1-I 4-J 2-J 1-J -D-
VOL.32 S-9 CHEMOTHERAPY Table 1 Minimum inhibitory concentrations of AC-1370, CPZ and CAZ Table 2 Efficacy of AC-1370 and CPZ against systemic infections in mice *Inoculum size: 106 cells/ml * 95% confidence
HASC2012corpus HASC Challenge 2010,2011 HASC2011corpus( 116, 4898), HASC2012corpus( 136, 7668) HASC2012corpus HASC2012corpus
HASC2012corpus 1 1 1 1 1 1 2 2 3 4 5 6 7 HASC Challenge 2010,2011 HASC2011corpus( 116, 4898), HASC2012corpus( 136, 7668) HASC2012corpus HASC2012corpus: Human Activity Corpus and Its Application Nobuo KAWAGUCHI,
maiji2007_cover_j_0907
27 CORPORATE PHILOSOPHY THE MEIJI DAIRIES GROUP CONTRIBUTES TO A HEALTHY AND HAPPY DAILY LIFE FOR OUR CUSTOMERS BY OFFERING NEW LEVELS OF VALUE IN FOOD. CONTENTS 2 4 6 1 1 11 12 13 14 16 18 19 2 22 23
橡アロマセラピー症状別処方例.PDF
1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20
Fig.1 Chemical structure of BAY o 9867
Fig.1 Chemical structure of BAY o 9867 CHEMOTHERAPY 43 Table 3 Antibacterial spectrum of gram negative bacteria Medium:Heart infusion agar (Nissui) Method:Agar dilution (Streak) CHEMOTHERAPY DEC 1985
Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL Right Posted at the Inst
Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL http://hdl.handle.net/10130/526 Right Posted at the Institutional Resources for Unique Colle Available from
3 4 3 2 4 1 4 2 4 2 1 3 1 1 4 1 1 16,000 14,000 12,000 W) S) RC) CB 10,000 8,000 6,000 4,000 2,000 0 12,000 11,500 11,000 10,500 10,000 9,500 9,000 550 540 530 520 510 500 490 480 470 460 450 2008 2009
[A](2): [B](4): DNA [B] [B](4):
: [B](4): DNA [B] [B](4):](/thumbs/91/104797401.jpg "[A](2): [B](4): DNA [B] [B](4):")
3 [A](2): 7 6 19.4 16.7 [A] 0 0.0 1 2.8 1 2.8 13 [A](1): 36.1 1974 1 3.0 2 5.6 1975 1 3.0 2 5.6 1980 1 3.0 4 11.1 1990 1 3.0 0 0.0 1993 1 3.0 36 100.0 1994 1 3.0 1999 1 3.0 [A](2): 2000 1 3.0 2001 5 15.2
2010 1 1 7 2 16 2 2 06in 3 3 錆 錆 06in 4 4 0.1 5 5 HCl Cl NaOH H Cl O 2 H H 2 O NaCl Na OH H 2 O NaCl 2010 6 6 ph3.0 30 mg/l 30 1 O-157 H7 2010 7 7 100 Cl 80 60 40 20 HClO ClO CL ph 10 100,000ppm 12 01
ら 乳酸菌やビフィズス菌の線毛の発見は遅れることとなった それが一転して 全ゲノム解析から得られた情報によって 線毛があるはず ということで仕事がなされたのである (1) 乳酸菌からの線毛の発見 Lactobacillus caseiグループのゲノム解析により spacbaがコードするのは菌体表層タ
麻布大学獣医学部動物応用科学科食品科学研究室教授森田英利 1. はじめに 乳酸菌として初めて全ゲノム解析が公表されたのは 2001 年のLactococcus lactis 1) であり Lactobacillus 属で最初の報告は 2003 年の Lactobacillus plantarum 2) である 一方 ビフィズス菌では Bifidobacterium longum 3) の全ゲノム解析の論文が2002
ニュースレター10-1.indd
The Japanese Society of Immunotoxicology 101192005 aaaa 12 2005172021 1-1-1 Tel. 03-5841-8205 / Dr. R.H. Pieters () "Immunotoxicology of therapeutics associated with allergy and autoimmunity" 2005 In
08-g-”O−}„j‹ê-4.02
200( 96 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 58 2 Apr. 585 1 17 MIC 1. (Transtracheal aspiration: TTA) TTA TTA TTA 1400 TTA (diffuse panbronchiolitis, DPB) 1) erythromycin(em) EM 12.5% 87.5% 2,3) EM EM
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
http://keirin.jp ...1 1....2 1.1...2 1.1.1...2 1.1.2...4 1.2...5 1.2.1...6 1.2.2...7 1.3...11 1.3.1...11 1.3.2...12 2....14 2.1...14 2.2...17 2.2.1 5...17 2.2.2...20 3....27 3.1...27 3.1.1...27 3.1.2...35
広島県獣医学会雑誌24号.indd
1 1 Study on the effects of dexamethasone administration in acute coccidiosis accompanied by bloody stools TOMOYASU KUROSE Shoubara Veterinary Clinical Center, P. F. A. M. A. A -1-, Nishihonmachi, Shoubara,
VOL. 17 NO. 7 CHEMOTHERAPY 1305 1) W. BRumFirr et al. : Clinical and laboratory studies with carbenicillin. Lancet 1: 1289~ 1293, 1967 2) E. T. KNUDSEN et al. : A new semisynthetic penicillin active against
14_井上洋.indd
10 205 241 2015 6 205 The disaster response laws and regulations in the early Meiji Hiroshi INOUE 1868 1885 18 1868 26 22 13 22 10 7 1868 1 1885 18 2 3 1885 4 10 5 206 5 17 395 1962 7 10 36 223 8 109 9
2 5 28 4 1 47 2
4 4 5 28 1 2 5 28 4 1 47 2 10 10 22 78 10 28 2 2 10% NHK 30% 32% 3 4 5 1 150 1 5 1 20 2 3 1 2008 2 2 2009 2009 3 3 4 DNA 1 3 2 1 3 3 1 5 3 5 8 18 8 30 5 3 2 60 1 5 2 3 60 2 2 2 60 1 1 5 150 6 3 1 2 150
株式会社ウェッズ
39th 1 2 39th 25,000 500 300 20,000 15,000 400 300 200 10,000 5,000 200 100 100 0 0 0 16,000 50 5 12,000 8,000 4,000 40 30 20 10 4 3 2 1 0 0 0 3 4 39th 5 6 39th 7 N E W P R O D U C T S 8 39th 9 10 CO.,LTD.
VOL. 34 S-2 CHEMOTH8RAPY 913
VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(
業績集2011.8より.xlsx
2011.4-2012.3 2011 4 pp.80-86 2011 4 pp.100-106 2011 4 pp.171-185 2011 7 pp26-29 2011 8 2011 8 pp56-61 2011 11 pp117-127 2011 11 pp.245-252 2011 11 2011 12 1 12 13 Osawa Y,Oguma Y Effects of whole-body
988 CHEMOTHERAPY NOV. 1971
988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical
